- Sections
- C - Chimiemétallurgie
- C07K - Peptides
- C07K 5/10 - Tétrapeptides
Détention brevets de la classe C07K 5/10
Brevets de cette classe: 764
Historique des publications depuis 10 ans
|
41
|
67
|
56
|
66
|
60
|
64
|
49
|
32
|
20
|
10
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| ISP Investments Inc. | 467 |
17 |
| Stealth Biotherapeutics Inc. | 170 |
12 |
| Stealth Biotherapeutics Corp | 36 |
11 |
| The University of British Columbia | 1487 |
11 |
| Lipotec, S.A. | 210 |
10 |
| Bristol-myers Squibb Company | 4896 |
9 |
| CARA Therapeutics, Inc. | 69 |
9 |
| Helix Biomedix Inc. | 31 |
8 |
| Endocyte, Inc. | 109 |
7 |
| The Regents of the University of California | 19784 |
6 |
| Mimetogen Pharmaceuticals, Inc. | 18 |
6 |
| Onyx Therapeutics, Inc. | 68 |
6 |
| S.i.s. Shulov Innovative Science Ltd. | 15 |
6 |
| Lactocore, Inc. | 7 |
6 |
| The Governing Council of The University of Toronto, | 1455 |
5 |
| Kyoto University | 2785 |
5 |
| Centre National de La Recherche Scientifique | 10284 |
4 |
| California Institute of Technology | 3958 |
4 |
| Agency for Science, Technology and Research | 3579 |
4 |
| University of Florida Research Foundation, Inc. | 3975 |
4 |
| Autres propriétaires | 614 |